Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free CRVS Stock Alerts

Corvus Pharmaceuticals (CRVS) Institutional Ownership

Corvus Pharmaceuticals logo
$14.59 -0.86 (-5.57%)
Closing price 04:00 PM Eastern
Extended Trading
$14.60 +0.01 (+0.07%)
As of 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Corvus Pharmaceuticals (NASDAQ:CRVS)

Current
Institutional Ownership
Percentage
46.64%
Number of
Institutional Buyers
(last 12 months)
76
Total
Institutional Inflows
(last 12 months)
$103.23M
Number of
Institutional Sellers
(last 12 months)
25
Total
Institutional Outflows
(last 12 months)
$39.72M
Get CRVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CRVS Institutional Buying and Selling by Quarter

Corvus Pharmaceuticals Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2026SEB Asset Management AB226,837$3.32M0.0%N/A0.270%
5/6/2026 Towerview LLC70,000$1.02M0.7%-50.0%0.083%
5/5/2026 Bank of New York Mellon Corp185,347$2.71M0.0%+40.8%0.220%
5/4/2026 Emerald Mutual Fund Advisers Trust459,253$6.72M0.3%N/A0.546%
5/4/2026 Emerald Advisers LLC686,216$10.04M0.3%N/A0.816%
5/4/2026 Teachers Retirement System of The State of Kentucky8,000$117K0.0%N/A0.010%
4/29/2026 Shelton Wealth Management LLC12,268$179K0.1%-21.6%0.015%
4/28/2026 Whittier Trust Co. of Nevada Inc.10,200$150K0.0%-8.9%0.012%
4/27/2026 Simplify Asset Management Inc.20,242$296K0.0%N/A0.024%
4/16/2026 SG Americas Securities LLC35,420$518K0.0%+76.9%0.042%
3/20/2026 Hsbc Holdings PLC59,269$451K0.0%-28.1%0.071%
2/19/2026Invesco Ltd.43,583$336K0.0%+12.7%0.052%
2/18/2026Virtus Investment Advisers LLC31,783$245K0.1%+18.4%0.038%
2/18/2026Wellington Management Group LLP314,683$2.42M0.0%+74.7%0.376%
2/18/2026RTW Investments LP447,607$3.45M0.0%-83.3%0.534%
2/18/2026Perceptive Advisors LLC692,441$5.33M0.1%-51.9%0.827%
2/18/2026Millennium Management LLC688,770$5.30M0.0%N/A0.822%
2/18/2026Bridgeway Capital Management LLC26,700$206K0.0%-60.0%0.032%
2/17/2026Logos Global Management LP500,000$3.85M0.2%N/A0.597%
2/17/2026ADAR1 Capital Management LLC465,875$3.59M0.3%N/A0.556%
2/17/2026MPM Bioimpact LLC2,743,671$21.13M2.4%N/A3.275%
2/17/2026Price T Rowe Associates Inc. MD34,105$263K0.0%+5.2%0.041%
2/17/2026Captrust Financial Advisors11,051$85K0.0%N/A0.013%
2/17/2026Fred Alger Management LLC144,381$1.11M0.0%N/A0.172%
2/17/2026ExodusPoint Capital Management LP86,720$668K0.0%N/A0.104%
2/17/2026Graham Capital Management L.P.19,274$148K0.0%N/A0.023%
2/17/2026Foresite Capital Management VI LLC1,381,233$10.64M3.2%-20.2%1.649%
2/16/2026Squarepoint Ops LLC104,820$807K0.0%N/A0.125%
2/16/2026Truvestments Capital LLC10,257$79K0.0%+86.1%0.012%
2/16/2026Verition Fund Management LLC21,382$165K0.0%N/A0.026%
2/16/2026Barclays PLC394,766$3.04M0.0%+27.7%0.471%
2/13/2026Marshall Wace LLP216,248$1.67M0.0%N/A0.258%
2/13/2026The Manufacturers Life Insurance Company 17,497$135K0.0%-6.6%0.021%
2/13/2026Rafferty Asset Management LLC99,724$768K0.0%N/A0.119%
2/13/2026Charles Schwab Investment Management Inc.171,173$1.32M0.0%-3.7%0.204%
2/13/2026State Street Corp2,788,223$21.47M0.0%+177.1%3.328%
2/13/2026Wells Fargo & Company MN62,623$482K0.0%+72.1%0.075%
2/12/2026DRW Securities LLC23,384$180K0.0%N/A0.028%
2/12/2026MetLife Investment Management LLC30,782$237K0.0%-8.4%0.037%
2/12/2026Alps Advisors Inc.61,318$472K0.0%N/A0.073%
2/11/2026DCF Advisers LLC729,000$5.61M1.5%N/A0.870%
2/11/2026Deutsche Bank AG56,039$432K0.0%+4.5%0.067%
2/11/2026Fox Run Management L.L.C.11,220$86K0.0%N/A0.013%
2/10/2026Goldman Sachs Group Inc.553,327$4.26M0.0%+24.2%0.661%
2/10/2026AXQ Capital LP12,601$97K0.0%-53.4%0.015%
2/10/2026Intech Investment Management LLC35,973$277K0.0%+37.5%0.043%
2/9/2026Geode Capital Management LLC1,473,026$11.35M0.0%+1.1%1.758%
2/6/2026 ProShare Advisors LLC13,764$106K0.0%+7.7%0.016%
2/4/2026 Towerview LLC140,000$1.08M0.8%-17.6%0.167%
1/29/2026 China Universal Asset Management Co. Ltd.18,169$140K0.0%+39.1%0.022%
1/26/2026 Shelton Wealth Management LLC15,638$120K0.1%+13.8%0.021%
1/26/2026 Mirae Asset Global Investments Co. Ltd.3,629$28K0.0%+26.0%0.005%
1/21/2026Palumbo Wealth Management LLC26,255$202K0.0%+11.2%0.035%
1/21/2026 Sowell Financial Services LLC17,000$131K0.0%+41.7%0.023%
1/16/2026 Tema Etfs LLC79,698$614K0.0%+34.6%0.107%
1/16/2026 Empirical Financial Services LLC d.b.a. Empirical Wealth Management167,400$1.29M0.0%-1.1%0.224%
1/9/2026 SG Americas Securities LLC20,021$154K0.0%N/A0.027%
1/1/2026JPMorgan Chase & Co.32,232$238K0.0%+6.0%0.043%
11/17/2025Quarry LP3,653$27K0.0%N/A0.005%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.27,525$203K0.0%-4.0%0.037%
11/17/2025Jain Global LLC27,618$204K0.0%N/A0.037%
11/17/2025Brevan Howard Capital Management LP15,300$113K0.0%N/A0.020%
11/17/2025Bank of America Corp DE151,966$1.12M0.0%+14.5%0.203%
11/14/2025Creative Planning25,299$186K0.0%N/A0.034%
11/14/2025Ancora Advisors LLC47,290$349K0.0%+9.7%0.063%
11/14/2025Two Sigma Investments LP203,360$1.50M0.0%-9.2%0.272%
11/13/2025 UBS Group AG162,074$1.19M0.0%+80.7%0.217%
11/13/2025BNP Paribas Financial Markets12,516$92K0.0%+125.9%0.017%
11/13/2025Russell Investments Group Ltd.6,661$49K0.0%N/A0.009%
11/12/2025Barclays PLC309,152$2.28M0.0%-10.0%0.414%
11/10/2025Palumbo Wealth Management LLC23,614$174K0.0%N/A0.032%
11/10/2025AXQ Capital LP27,051$199K0.1%N/A0.036%
11/10/2025 China Universal Asset Management Co. Ltd.13,061$96K0.0%-15.7%0.017%
11/7/2025NEOS Investment Management LLC59,202$436K0.0%N/A0.079%
11/7/2025GSA Capital Partners LLP401,407$2.96M0.2%+25.9%0.538%
11/7/2025Vanguard Group Inc.3,471,925$25.59M0.0%+5.8%4.649%
11/7/2025JPMorgan Chase & Co.32,232$238K0.0%+6.0%0.043%
11/6/2025Rhumbline Advisers82,590$609K0.0%+8.7%0.111%
11/3/2025New York State Common Retirement Fund18,800$139K0.0%-21.0%0.025%
10/20/2025Masso Torrence Wealth Management Inc.17,000$125K0.1%-66.0%0.023%
10/9/2025 Shelton Wealth Management LLC13,742$101K0.0%N/A0.018%
8/28/2025 China Universal Asset Management Co. Ltd.15,488$62K0.0%+20.2%0.021%
8/27/2025Squarepoint Ops LLC138,462$554K0.0%+37.0%0.186%
8/15/2025Sender Co & Partners Inc.12,995$52K0.0%N/A0.017%
8/15/2025Perceptive Advisors LLC1,438,595$5.75M0.5%N/A1.931%
8/15/2025Bridgeway Capital Management LLC66,700$267K0.0%+61.5%0.090%
8/15/2025Bank of America Corp DE132,729$531K0.0%+34.7%0.178%
8/14/2025Orbimed Advisors LLC7,165,006$28.66M0.8%+3.2%9.616%
8/14/2025Jane Street Group LLC10,118$40K0.0%-96.2%0.014%
8/14/2025Raymond James Financial Inc.124,496$498K0.0%+15.1%0.167%
8/14/2025Bayesian Capital Management LP17,500$70K0.0%N/A0.023%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.28,661$115K0.0%N/A0.038%
8/14/2025Caption Management LLC21,827$87K0.0%-56.3%0.029%
8/14/2025The Manufacturers Life Insurance Company 19,098$76K0.0%N/A0.026%
8/14/2025Qube Research & Technologies Ltd43,969$176K0.0%-90.2%0.059%
8/13/2025Marshall Wace LLP201,651$807K0.0%+30.3%0.271%
8/13/2025Invesco Ltd.40,607$162K0.0%N/A0.054%
8/13/2025New York State Common Retirement Fund23,800$95K0.0%N/A0.032%
8/13/2025 Hsbc Holdings PLC84,273$332K0.0%N/A0.113%
8/12/2025Foresite Capital Management VI LLC1,731,233$6.93M3.9%+9.5%2.323%


CRVS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CRVS shares?

During the previous two years, 113 institutional investors and hedge funds held shares of Corvus Pharmaceuticals. The most heavily invested institutionals were Orbimed Advisors LLC ($28.66M), Vanguard Group Inc. ($25.59M), State Street Corp ($21.47M), MPM Bioimpact LLC ($21.13M), Point72 Asset Management L.P. ($16.21M), Samlyn Capital LLC ($12.93M), and Vivo Capital LLC ($11.96M).Learn more on Corvus Pharmaceuticals' institutional investors.

What percentage of Corvus Pharmaceuticals' stock is owned by institutional investors?

46.64% of Corvus Pharmaceuticals' stock is owned by institutional investors. Learn more on CRVS's institutional investor holdings.

Which institutional investors have been buying Corvus Pharmaceuticals' stock?

Of the 104 institutional investors that purchased Corvus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($5.96M), Samlyn Capital LLC ($3.77M), MPM Bioimpact LLC ($2.74M), RTW Investments LP ($2.68M), State Street Corp ($1.84M), Foresite Capital Management VI LLC ($1.73M), and Perceptive Advisors LLC ($1.44M).

How much institutional buying is happening at Corvus Pharmaceuticals?

Institutional investors have bought a total of 13,893,501 shares in the last 24 months. This purchase volume represents approximately $103.23M in transactions.

Which of Corvus Pharmaceuticals' major shareholders have been selling company stock?

Of the 25 institutional investors that sold Corvus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Samlyn Capital LLC ($2.60M), RTW Investments LP ($2.23M), Perceptive Advisors LLC ($746.15K), Qube Research & Technologies Ltd ($405.11K), Foresite Capital Management VI LLC ($350K), Jane Street Group LLC ($256.79K), and Towerview LLC ($100K).

How much institutional selling is happening at Corvus Pharmaceuticals?

Institutional investors have sold a total of 7,015,304 shares in the last 24 months. This volume of shares sold represents approximately $39.72M in transactions.


Related Companies

This page (NASDAQ:CRVS) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel